BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10504054)

  • 1. Effect of retinoic acid on plasminogen activator expression in human melanoma cells.
    Alexander CL; Edward M; MacKie RM
    Melanoma Res; 1999 Aug; 9(4):360-7. PubMed ID: 10504054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid.
    Alexander CL; Edward M; MacKie RM
    Br J Cancer; 1999 Jul; 80(10):1494-500. PubMed ID: 10408388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A; Kramer MD; Schirrmacher V; Brunner G
    Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells.
    Meissauer A; Kramer MD; Hofmann M; Erkell LJ; Jacob E; Schirrmacher V; Brunner G
    Exp Cell Res; 1991 Feb; 192(2):453-9. PubMed ID: 1899072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor beta 2 induction.
    Lansink M; Kooistra T
    Blood; 1996 Jul; 88(2):531-41. PubMed ID: 8695801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
    Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical interaction between retinoic acid receptor and Sp1: mechanism for induction of urokinase by retinoic acid.
    Suzuki Y; Shimada J; Shudo K; Matsumura M; Crippa MP; Kojima S
    Blood; 1999 Jun; 93(12):4264-76. PubMed ID: 10361124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transforming growth factor-beta on plasminogen activator production of cultured human uveal melanoma cells.
    Park SS; Li L; Korn TS; Mitra MM; Niederkorn JY
    Curr Eye Res; 1996 Jul; 15(7):755-63. PubMed ID: 8670784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines.
    van der Leede BM; van den Brink CE; van der Saag PT
    Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline-induced modulation of melanoma cell growth, adhesion and lymphokine activated killer cell-mediated lysis.
    Alexander CL; Edward M; MacKie RM
    Melanoma Res; 1999 Feb; 9(1):31-9. PubMed ID: 10338332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells.
    Clifford JL; Petkovich M; Chambon P; Lotan R
    Mol Endocrinol; 1990 Oct; 4(10):1546-55. PubMed ID: 2178220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
    Tienari J; Alanko T; Lehtonen E; Saksela O
    Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9,13-di-cis-Retinoic acid induces the production of tPA and activation of latent TGF-beta via RAR alpha in a human liver stellate cell line, LI90.
    Imai S; Okuno M; Moriwaki H; Muto Y; Murakami K; Shudo K; Suzuki Y; Kojima S
    FEBS Lett; 1997 Jul; 411(1):102-6. PubMed ID: 9247151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratocarcinoma F9 cells induced to differentiate with sodium butyrate produce both tissue-type and urokinase-type plasminogen activators.
    Takeda M; Kosaka M; Nishina Y; Sawada K; Matsumoto K; Nishimune Y
    J Cell Biochem; 1992 Jul; 49(3):284-9. PubMed ID: 1644865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid priming potentiates the induction of urokinase-type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells.
    Mira-y-Lopez R
    J Cell Physiol; 1991 Apr; 147(1):46-54. PubMed ID: 1645361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
    Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
    Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. tPA of human keratinocytes: contribution to cell surface-associated plasminogen activation and upregulation by retinoic acid.
    Buessecker F; Reinartz J; Kramer MD
    Exp Dermatol; 1995 Dec; 4(6):357-64. PubMed ID: 8608343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue.
    Dow MP; Bakke LJ; Cassar CA; Peters MW; Pursley JR; Smith GW
    Biol Reprod; 2002 May; 66(5):1413-21. PubMed ID: 11967205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferons and retinoids enhance and dexamethasone suppresses urokinase-mediated plasminogen activation in promyelocytic leukemia cells.
    Mustjoki S; Tapiovaara H; Sirén V; Vaheri A
    Leukemia; 1998 Feb; 12(2):164-74. PubMed ID: 9519778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility of cultured human melanoma cell lines to enhancement by retinoic acid of intercellular adhesion molecule 1 expression.
    Wang Z; Cao Y; D'Urso CM; Ferrone S
    Cancer Res; 1992 Sep; 52(17):4766-72. PubMed ID: 1355009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.